Stockholders' Equity - Registered Direct Stock Offering and Concurrent Warrant Issuance (Details) - Registered direct offering	1 Months Ended	2 Months Ended
	Jul. 31, 2022 USD ($) Vote $ / shares shares	Sep. 30, 2022 USD ($)	Aug. 02, 2022 shares	Jul. 29, 2022 USD ($)
Stockholders' Equity
Shares issuable upon conversion of convertible preferred stock | shares	8,000,000
Number of shares that can be purchased upon exercise of warrants (in shares) | shares	8,000,000
Exercise price (in dollars per share) | $ / shares	$ 0.263
Gross Proceeds	$ 2,000,000
Net Proceeds	1,600,000
Payment of underwriting discounts and commissions	$ 400,000
Series A convertible preferred stock
Stockholders' Equity
Issuance of stock (in shares) | shares	1,800
Series B convertible preferred stock
Stockholders' Equity
Issuance of stock (in shares) | shares	200
Number Of Votes Per Share | Vote	25,000,000
Common Stock Warrant Liability
Stockholders' Equity
Warrants term	5 years 6 months
Gross Proceeds	$ 1,519,000
Beginning balance		$ 1,519,000
Change in fair value		(651)
Ending balance		$ 868
Common Stock Warrant Liability | Level 3 | Estimated remaining term
Stockholders' Equity
Warrant liability measurement input		4.8		5.0
Common Stock Warrant Liability | Level 3 | Risk-free interest rate
Stockholders' Equity
Warrant liability measurement input		0.041		0.027
Common Stock Warrant Liability | Level 3 | Volatility
Stockholders' Equity
Warrant liability measurement input		1.055		1.043
Common Stock Warrant Liability | Selling, general and administrative expenses
Stockholders' Equity
Payment of underwriting discounts and commissions	300,000
Series A and Series B Preferred Stock
Stockholders' Equity
Gross Proceeds	481,000
Payment of underwriting discounts and commissions	$ 100,000
Shares issued upon conversion | shares			8,000,000